|
|
||||||||
Ann Thorac Surg 2001;71:993-994
© 2001 The Society of Thoracic Surgeons
a Department of Pulmonary & Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Over the past 20 years, lung transplantation has become standard therapy for a variety of end-stage lung diseases. With experience, better immunosuppression, and prophylaxis, there has been gradual improvement in survival; yet, lung transplantation lags behind improvement with other solid organs. Airway complications are unique to lung transplantation; they may not always be preventable but are often treatable. Their recognition and proper management would certainly palliate symptoms and could improve survival.
Herrera and associates describe
Related Article
Ann. Thorac. Surg. 2001 71: 989-993.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |